GlassScriptPhysician profile
Robert Charles Dean
NPI 1326119025
$1,314.57
in general payments reported to CMS, 2019-2025
16 companies · $366 in 2025
The $366 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.82 · 2021: $32.77 · 2022: $352 · 2023: $317 · 2024: $212 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $335.93 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Boston Scientific Corporation | $211.87 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Lithoclast |
| Endo Pharmaceuticals INC. | $175.16 | 2019-2023 | Xiaflex |
| 180 Medical, INC. | $90.47 | 2025 | |
| Sumitomo Pharma America, INC. | $86.67 | 2023-2025 | Orgovyx, Gemtesa |
| Tolmar, INC. | $85.91 | 2024-2025 | Eligard, Jatenzo |
| Endo USA, INC. | $69.30 | 2024-2025 | Xiaflex |
| Agiliti Surgical, INC. | $38.72 | 2025 | Sonablate Hifu |
| Janssen Biotech, INC. | $33.50 | 2025 | Erleada |
| Myovant Sciences INC. | $32.77 | 2021 | |
| Pfizer INC. | $31.41 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $26.75 | 2023 | Exparel |
| Procept Biorobotics Corporation | $25.99 | 2025 | |
| Urogen Pharma, INC. | $25.56 | 2025 | |
| Ferring Pharmaceuticals INC. | $24.13 | 2025 | Adstiladrin |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $20.43 | 2024 | Uretero-Reno Videoscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.